Cargando…
Functional desensitization of the β(2) adrenoceptor is not dependent on agonist efficacy
Chronic treatment with β(2) adrenoceptor agonists is recommended as a first-line maintenance therapy for chronic obstructive pulmonary disease (COPD). However, a potential consequence of long-term treatment may be the loss of functional response (tachyphylaxis) over time. In this study, we have inve...
Autores principales: | Rosethorne, Elizabeth M, Bradley, Michelle E, Kent, Toby C, Charlton, Steven J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317232/ https://www.ncbi.nlm.nih.gov/pubmed/25692019 http://dx.doi.org/10.1002/prp2.101 |
Ejemplares similares
-
The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
por: Bawa-Khalfe, Tasneem, et al.
Publicado: (2007) -
Structure and Function of an Irreversible Agonist-β(2) Adrenoceptor complex
por: Rosenbaum, Daniel M., et al.
Publicado: (2011) -
β(2)‐Adrenoceptor agonist activity of higenamine
por: Hudzik, Thomas J., et al.
Publicado: (2021) -
Paradoxical bronchoconstriction caused by β(2)-adrenoceptor agonists
por: Ayed, Khadija, et al.
Publicado: (2020) -
A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)